Precision analysis backed by ISO 17025 accreditation, state-of-the-art instrumentation, and decades of pharmaceutical expertise.
Our comprehensive analytical capabilities span the entire spectrum of pharmaceutical characterization. With state-of-the-art instrumentation and highly trained scientists, we deliver reliable, reproducible results that meet the most stringent regulatory requirements. Whether you need routine quality control or advanced structural elucidation, ChemContract provides the analytical expertise your program requires.
Custom analytical methods developed and validated to ICH Q2(R1) standards for maximum confidence in your data.
Advanced techniques including NMR, MS, and X-ray diffraction to fully elucidate molecular structure and properties.
Comprehensive testing programs ensuring product quality throughout development and commercial lifecycle.
Industry-leading equipment enabling rapid, accurate analysis across diverse molecular properties and compound classes.
1D and 2D NMR analysis for structure elucidation, stereochemistry assignment, and dynamic studies.
LC-MS/MS and GC-MS platforms for compound identification, purity analysis, and metabolite detection.
High-performance liquid chromatography for purity assessment, impurity profiling, and related substances analysis.
Single crystal and powder XRD for polymorphism screening and crystal structure determination.
DSC and TGA for melting point determination, thermal stability assessment, and decomposition profiling.
CHN analysis, trace metals detection, and elemental composition determination via ICP-OES.
All analyses meet or exceed the most stringent global pharmaceutical and analytical standards.
Methods and practices align with FDA guidance documents and 21 CFR requirements for pharmaceutical manufacturing.
European Medicine Agency guidelines compliance ensuring acceptance across EU and international markets.
International Council for Harmonisation validation guidance ensuring data integrity and method robustness.
Pharmacopeial standards from United States, European, and Japanese pharmacopeias integrated into testing protocols.
Current Good Manufacturing Practice compliance ensuring quality systems meet pharmaceutical manufacturing standards.
International standard for competence of testing and calibration laboratories with third-party verification.
Common questions about our analytical capabilities and testing services.
Turnaround times vary depending on the complexity and scope of analysis. Routine testing typically requires 5-10 business days, while advanced characterization studies may take 2-4 weeks. We provide expedited services for urgent projects. Contact our team for specific timelines for your analysis.
Yes, we specialize in method development and validation services. Our team can work with you to develop custom analytical methods tailored to your specific compound properties and regulatory requirements. All validations follow ICH Q2(R1) guidelines for maximum compliance and acceptance by regulatory authorities.
Sample requirements depend on the analytical techniques requested. For typical pharmaceutical compounds, we recommend 100-500 mg for comprehensive analysis including NMR, MS, and HPLC characterization. We can work with smaller quantities for preliminary analysis. Our scientists will advise on optimal sample sizes during project planning.
Absolutely. Our comprehensive analytical reports are formatted for direct inclusion in IND, CTA, NDA, and ANDA submissions. Reports include detailed methodology, quality control data, chromatograms, spectra, and full compliance documentation with relevant pharmacopeial and ICH standards, supporting regulatory acceptance worldwide.
Our team of expert analysts is ready to help accelerate your research and development timeline with precise, reliable analytical data.
Hi there! How can we help you today?